Aldosterone dysregulation plays an important pathogenic role in hard-to-control hypertension. In several studies, baxdrostat, an aldosterone synthase inhibitor, reduced the seated systolic blood ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback